Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Articles published by GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Immunocore presents Phase 1 data for hepatitis B candidate at AASLD’s The Liver Meeting
November 07, 2025
From
Immunocore Holdings plc
Via
GlobeNewswire
Tickers
IMCR
AirJoule Technologies Schedules Release of Third Quarter 2025 Results and Conference Call
November 07, 2025
From
AirJoule Technologies Corporation
Via
GlobeNewswire
Tickers
AIRJ
Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences
November 07, 2025
From
Centessa Pharmaceuticals plc
Via
GlobeNewswire
Tickers
CNTA
Atea Pharmaceuticals Presents New Data Supporting the Fixed-Dose Combination of Bemnifosbuvir and Ruzasvir as a Potential Best-in-Class Regimen for Treatment of Hepatitis C Virus Infection at The Liver Meeting® 2025
November 07, 2025
From
Atea Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
AVIR
Dycom Industries, Inc. to Host Fiscal 2026 Third Quarter Results Conference Call
November 07, 2025
From
Dycom Industries Inc
Via
GlobeNewswire
Tickers
DY
Dupixent® (dupilumab) Pivotal Trial Met All Primary and Secondary Endpoints, Reducing Signs and Symptoms of Allergic Fungal Rhinosinusitis (AFRS); sBLA Accepted for FDA Priority Review
November 07, 2025
From
Regeneron Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
REGN
Assembly Biosciences Presents Positive Phase 1b Data for Next-Generation Capsid Assembly Modulator ABI-4334 at AASLD The Liver Meeting®
November 07, 2025
From
Assembly Biosciences, Inc.
Via
GlobeNewswire
Tickers
ASMB
ESET to aid MSPs by integrating with ConnectWise Asio
November 07, 2025
From
ESET
Via
GlobeNewswire
Vor Bio to Participate in Upcoming Investor Conferences
November 07, 2025
From
Vor Biopharma
Via
GlobeNewswire
Tickers
VOR
Rivus Pharmaceuticals Announces New Data from Phase 2 M-ACCEL Trial of HU6 in MASH in Late-Breaker Oral Presentation at AASLD The Liver Meeting® 2025
November 07, 2025
From
Rivus Pharmaceuticals, Inc.
Via
GlobeNewswire
illumin Reports Third Quarter 2025 Financial Results
November 07, 2025
From
illumin
Via
GlobeNewswire
Tickers
ILLMF
TSX:ILLM
Barrick Completes Sale of Alturas Project
November 07, 2025
From
BARRICK MINING CORPORATION
Via
GlobeNewswire
Tickers
B
TSX:ABX
Copyseeker Pioneers Visual Search Integration in AI with Model Context Protocol Launch
November 07, 2025
From
MB AI Brothers
Via
GlobeNewswire
Barinthus Bio Reports Third Quarter 2025 Financial Results and Updates on Corporate Developments
November 07, 2025
From
Barinthus Biotherapeutics
Via
GlobeNewswire
Tickers
BRNS
Abeona Therapeutics® Announces Date of Third Quarter Financial Results and Upcoming Investor Conference Participation
November 07, 2025
From
Abeona Therapeutics Inc.
Via
GlobeNewswire
Tickers
ABEO
Rhythm Pharmaceuticals Announces FDA Extension of Review Period for IMCIVREE® (setmelanotide) for Patients with Acquired Hypothalamic Obesity
November 07, 2025
From
Rhythm Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
RYTM
Context Therapeutics Highlights CT-95 and CT-202 Programs at 2025 SITC Annual Meeting
November 07, 2025
From
Context Therapeutics Inc.
Via
GlobeNewswire
Tickers
CNTX
Onex Reports Third Quarter 2025 Results
November 07, 2025
From
ONEX Corporation
Via
GlobeNewswire
Tickers
TSX:ONEX
Quantum Biopharma Reports Strong Third Quarter Results Maintaining ‘No Going Concern’ Status with Cash Runway Extending Beyond March 2027, and $572,000 USD Gains in Crypto Portfolio
November 07, 2025
From
Quantum BioPharma
Via
GlobeNewswire
Tickers
CSE:QNTM
QNTM
Akero Therapeutics Presents New Analyses from Phase 2b SYMMETRY and HARMONY Trials of Efruxifermin at 76th Annual AASLD The Liver Meeting® 2025
November 07, 2025
From
Akero Therapeutics Inc.
Via
GlobeNewswire
Tickers
AKRO
RYTHM, Inc. Reports Third Quarter 2025 Results
November 07, 2025
From
RYTHM, Inc.
Via
GlobeNewswire
Tickers
RYM
GenVivo to Present Phase 1 Trial Results for GEN2, A Personalizing Systemic Cancer Immunotherapy, at the 2025 Society for Immunotherapy of Cancer (SITC) Annual Meeting
November 07, 2025
From
GenVivo, Inc.
Via
GlobeNewswire
Mobilicom Secures Follow-On Production Order from Asia-Based Tier-1 Robotics Manufacturer Bringing Cumulative Orders to $315,000
November 07, 2025
From
Mobilicom Limited
Via
GlobeNewswire
Tickers
MOB
MOBBW
Brookfield Infrastructure Reports Strong Third Quarter 2025 Results
November 07, 2025
From
Brookfield Infrastructure Partners LP; Brookfield Infrastructure Corporation
Via
GlobeNewswire
Tickers
BIP
BIPC
TSX:BIP-UN
TSX:BIPC
Prime Medicine Reports Third Quarter 2025 Financial Results and Provides Business Updates
November 07, 2025
From
Prime Medicine, Inc.
Via
GlobeNewswire
Tickers
PRME
Whitestone REIT Acquires Primely Located World Cup Plaza in Frisco, Texas
November 07, 2025
From
Whitestone REIT
Via
GlobeNewswire
Tickers
WSR
K-Tech Rings the Closing Bell on the Nasdaq
November 07, 2025
From
K-Tech Solutions Company Limited
Via
GlobeNewswire
Tickers
KMRK
AMC Networks Inc. Reports Third Quarter 2025 Results
November 07, 2025
From
AMC Networks Inc.
Via
GlobeNewswire
Tickers
AMCX
Seer and Collaborators Unveil Broad New Data Demonstrating the Translational Power of Deep Proteomics at HUPO 2025
November 07, 2025
From
Seer, Inc.
Via
GlobeNewswire
Tickers
SEER
Perella Weinberg Reports Third Quarter 2025 Results
November 07, 2025
From
Perella Weinberg Partners Group LP
Via
GlobeNewswire
Tickers
PWP
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.